These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, Parisi JE, Dickson DW. Neurology; 2006 Jan 10; 66(1):41-8. PubMed ID: 16401843 [Abstract] [Full Text] [Related]
3. Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. Tuite PJ, Clark HB, Bergeron C, Bower M, St George-Hyslop P, Mateva V, Anderson J, Knopman DS. Arch Neurol; 2005 Sep 10; 62(9):1453-7. PubMed ID: 16157754 [Abstract] [Full Text] [Related]
4. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I, Barrachina M, Puig B. Acta Neuropathol; 2002 Dec 10; 104(6):583-91. PubMed ID: 12410379 [Abstract] [Full Text] [Related]
5. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. Scaravilli T, Tolosa E, Ferrer I. Mov Disord; 2005 Aug 10; 20 Suppl 12():S21-8. PubMed ID: 16092076 [Abstract] [Full Text] [Related]
6. Atypical progressive supranuclear palsy with corticospinal tract degeneration. Josephs KA, Katsuse O, Beccano-Kelly DA, Lin WL, Uitti RJ, Fujino Y, Boeve BF, Hutton ML, Baker MC, Dickson DW. J Neuropathol Exp Neurol; 2006 Apr 10; 65(4):396-405. PubMed ID: 16691120 [Abstract] [Full Text] [Related]
7. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies. Ferrer I, Hernández I, Boada M, Llorente A, Rey MJ, Cardozo A, Ezquerra M, Puig B. Acta Neuropathol; 2003 Nov 10; 106(5):419-35. PubMed ID: 12955398 [Abstract] [Full Text] [Related]
8. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. Katsuse O, Iseki E, Arai T, Akiyama H, Togo T, Uchikado H, Kato M, de Silva R, Lees A, Kosaka K. Acta Neuropathol; 2003 Sep 10; 106(3):251-60. PubMed ID: 12802605 [Abstract] [Full Text] [Related]
9. Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration? Tan CF, Piao YS, Kakita A, Yamada M, Takano H, Tanaka M, Mano A, Makino K, Nishizawa M, Wakabayashi K, Takahashi H. Acta Neuropathol; 2005 Mar 10; 109(3):329-38. PubMed ID: 15841415 [Abstract] [Full Text] [Related]
10. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. Ingelsson M, Ramasamy K, Russ C, Freeman SH, Orne J, Raju S, Matsui T, Growdon JH, Frosch MP, Ghetti B, Brown RH, Irizarry MC, Hyman BT. Acta Neuropathol; 2007 Nov 10; 114(5):471-9. PubMed ID: 17721707 [Abstract] [Full Text] [Related]
11. Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration. Kasashima S, Oda Y. Acta Neuropathol; 2003 Feb 10; 105(2):117-24. PubMed ID: 12536222 [Abstract] [Full Text] [Related]
13. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. Kertesz A, Munoz D. Dement Geriatr Cogn Disord; 2004 Feb 10; 17(4):282-6. PubMed ID: 15178937 [Abstract] [Full Text] [Related]
14. The evolution and pathology of frontotemporal dementia. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. Brain; 2005 Sep 10; 128(Pt 9):1996-2005. PubMed ID: 16033782 [Abstract] [Full Text] [Related]
15. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis]. Morimatsu M, Negoro K, Mori H. Rinsho Shinkeigaku; 2004 Nov 10; 44(11):982-5. PubMed ID: 15651349 [Abstract] [Full Text] [Related]
16. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. Chalmers KA, Love S. J Neuropathol Exp Neurol; 2007 Nov 10; 66(11):1019-26. PubMed ID: 17984683 [Abstract] [Full Text] [Related]
17. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Gröschel K, Hauser TK, Luft A, Patronas N, Dichgans J, Litvan I, Schulz JB. Neuroimage; 2004 Feb 10; 21(2):714-24. PubMed ID: 14980574 [Abstract] [Full Text] [Related]
18. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Arai T, Ikeda K, Akiyama H, Tsuchiya K, Iritani S, Ishiguro K, Yagishita S, Oda T, Odawara T, Iseki E. Acta Neuropathol; 2003 May 10; 105(5):489-98. PubMed ID: 12677450 [Abstract] [Full Text] [Related]
19. Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration. Mimuro M, Yoshida M. Neuropathology; 2020 Feb 10; 40(1):57-67. PubMed ID: 31515852 [Abstract] [Full Text] [Related]
20. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Jellinger KA. Neurodegener Dis; 2008 Feb 10; 5(6):339-46. PubMed ID: 18349518 [Abstract] [Full Text] [Related] Page: [Next] [New Search]